V

VistaGen Therapeutics

D
VTGN
USD
0.025
(0.8091%)
Market Closed
2,054.00
Volume
-2.25
EPS
-
Div Yield
-3.349462
P/E
84,276,658.31
Market Cap
Today
-1.7350%
1 Week
0.484%
1 Month
8.537%
6 Months
-33.155%
12 Months
-10.231%
Year To Date
-39.632%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
G
GERN
0.005
(0.1168%)
USD
C
CRVS
-0.74
(-7.7568%)
USD
A
ACER
(%)
USD
Z
ZYNE
(%)
USD
O
OBSV
0.005
(4.0323%)
USD
P
PTN
-0.005
(-0.4255%)
USD
V
VRNA
0.57
(1.5164%)
USD
A
AGEN
-0.385
(-8.9017%)
USD
T
TRVN
-2.02
(-44.9889%)
USD

Title:
VistaGen Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
Do you need help or have a question?
Contact Us